The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results

ÇÖMLEKÇİ, Abdurrahman; İLKOVA, Hasan; DAMCI, Taner; ayvaz, goksun; Karşıdağ, Kubilay

The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results

Hasan İLKOVA, (İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Endokrinoloji ve Metabolizma Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Taner DAMCI, (İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Endokrinoloji ve Metabolizma Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Kubilay KARŞIDAĞ, (İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Endokrinoloji ve Metabolizma Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Abdurrahman ÇÖMLEKÇİ, (Dokuz Eylül Üniversitesi, Tıp Fakültesi, Endokrinoloji ve Metabolizma Bilim Dalı, İzmir, Türkiye)

Göksun AYVAZ (Gazi Üniversitesi, Tıp Fakültesi, Endokrinoloji ve Metabolizma Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Turkish Journal of Endocrinology and Metabolism

24 2

Yıl: 2016 Cilt: 20 Sayı: 3 Sayfa Aralığı: 88 - 96 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results

Öz:

Amaç: Obezite, hareketsiz yaşam tarzı ve yaşlanan popülasyon Türkiye'de tip 2 diyabeti (T2DM) arttırmaktadır ve diyabete karşı savaş için güncel ve standardize edilmiş bilgilere ihtiyaç vardır. Bu yazıda uluslarası, çok merkezli gözlemsel bir çalışmanın Türkiye'ye ait beşinci dönem sonuçları değerlendirilmiştir. Gereç ve Yöntem: Bu çalışma diyabet hasta profili, tedavi seçenekleri, komplikasyonlar, kardiovasküler risk faktörleri, ayrıca hastaların sağlık anketi (PHQ-9) sonuçlarının değerlendirildiği kesitsel bir çalışma olarak yürütülmüştür. Bulgular: Bu çalışma Türkiye'de 13 Aralık 2011 ve 26 Ocak 2012 tarihleri arasında 94 araştırmacı tarafından yürütülmüş ve çalışmaya 842 T2DM, 115 tip 1 diyabet (T1DM) hastası alınmıştır. Hastaların %52'si oral anti diyabetik ajan (OAD), %29'u OAD + insülin, %18'i ise sadece insülin tedavisi almıştır. Hastaların %88'inde en az bir mikrovasküler komplikasyon ve %99'unda en az bir kardiyovasküler risk faktörü tespit edilmiştir. T1DM hastaların sadece %27'si, T2DM hastaların ise sadece %28'i, <%7 olan hedef hemoglobin A1c seviyesine ulaşabilmiştir. PHQ-9 sonuçları hastaların çoğunluğunun (T1DM ve T2DM için %79) depresif olmadığını göstermiştir. Tartışma: Önerilen optimal glisemik değerlere ulaşılması ve korunması etkili diyabet tedavisi için şarttır. Türkiye'de T2DM hastalarının neredeyse %72'si bu hedeflere ulaşamamaktadır. Hastaların diyabet eğitimine ve yaşam tarzında değişiklik yapmalarına ihtiyaç vardır.

Anahtar Kelime:

Konular: Endokrinoloji ve Metabolizma

Uluslararası Diyabet Tedavi Pratikleri Kayıt Çalışması - Türkiye 5. Dönem Sonuçları

Öz:

Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing in Turkey due to rising obesity rates, sedentary life styles and Turkey's aging population; up-to-date and standardized data collection is required for the global fight against diabetes. The data collected from Turkey during the 5th wave of a multinational, multi-center and observational study are evaluated in this article.Material and Method: The International Diabetes Management Practices Study (IDMPS) which is an international, observational multicenter, cross-sectional study, evaluated demographic and clinical characteristics of diabetic patients, treatment modalities, complications, cardiovascular risk factors and also reported the results of the patient health questionnaire (PHQ-9).Results: This study consisted of 842 T2DM and 115 Type 1 diabetes mellitus (T1DM) patients and was carried out by 94 doctors in Turkey between December 13th 2011 and January 26th 2012. Data revealed that 52% of patients were treated with oral anti-diabetic (OAD) drugs only, 29% were treated with OAD + insulin, and 18% of subjects were treated with insulin alone. 88% of T2DM patients had at least one microvascular complication and 99% had at least one cardiovascular risk factor. Only 27% of T1DM and 28% of T2DM patients reached the target hemoglobin A1c value of <7%. PHQ-9 results revealed that majority of patients did not have a depressive disorder (79% for both T1DM and T2DM).Discussion: Attainment and maintenance of the internationally recommended optimal glycemic values is essential for effective treatment of diabetes. Almost 72% of T2DM patients in Turkey did not reach the target values. Diabetes patient education aiming to provide the knowledge necessary to make and maintain lifestyle changes is necessary.

Anahtar Kelime:

Konular: Endokrinoloji ve Metabolizma

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

IDF Diabetes Atlas seventh edition. IDF, Bruxelles, 2016. https://www.idf.org/ sites/default/files/EN_7E_Atlas_Full_0.pdf Accessed on 12.03.2016
Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003;29:6S9-6S18.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787.
International Diabetes Federation website .Accessed on 14.01.2014 http:// www.idf.org/worlddiabetesday/toolkit/gp/facts-figures
Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405.
Williams R. Medical and economic case for prevention of type 2 diabetes and cardiovascular disease. Eur Heart J Suppl 2005;7(Suppl D):14-17.
He effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
ADA (2003) "Clinical Practice Recommendations 2003." Diabetes Care 26: Suppl 1.
Mottur-Pilson C, Snow V, Bartlett K. Physician explanations for failing to comply with "best practices". Eff Clin Pract 2001;4:207-213.
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework of improvement. JAMA 1999;282:1458-1465.
Geographic patters of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group. Diabetes 1998;37:1113-1119.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744.
Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, Bastar I, Tütüncü Y, Sargin M, Dinççag N, Karsidag K,Kalaça S, Ozcan C, King H. Population- based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP)). Diabetes Care 2002;25:1551- 1556.
Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-180.
Meader N, Mitchell AJ, Chew-Graham C, Goldberg D, Rizzo M, Bird V, Kessler D, Packham J, Haddad M, Pilling S. Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. Br J Gen Pract 2011;61:808-820.
Twist K, Stahl D, Amiel SA, Thomas S, Winkley K, Ismail K. Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med 2013;75:791-797.
Zhang Y, Ting R, Lam M, Lam J, Nan H, Yeung R, Yang W, Ji L, Weng J, Wing YK, Sartorius N, Chan JC. Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes. J Affect Disord 2013;151:660-666.
Schmitz N, Gariépy G, Smith KJ, Malla A, Wang J, Boyer R, Strychar I, Lesage A. The pattern of depressive symptoms in people with type 2 diabetes: a prospective community study. J Psychosom Res 2013;74:128-134.
Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, Ilkova H, Ramachandran A, Aschner P;IDMPS Investigators. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practices Study (IDMPS). Diabetes Care 2009;32:227-233.
TEMD Diabetes Mellitus Çalışma ve Eğitim Grubu. Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu. 8. Baskı, Bayt Matbaacılık, Mayıs 2016. Ankara.
Ringborg A, Cropet C, Jönsson B, Gagliardino JJ, Ramachandran A, Lindgren P. Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS). Int J Clin Pract 2009;63:997-1007.
Degli Esposti L, Saragoni S, Buda S, Sturani A, Degli Esposti E. Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases. Clinicoecon Outcomes Res 2013:5;193-201.
Shetty S, Secnik K, Oglesby AK. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. J Manag Care Pharm 2005;11:559-564.
Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001;24:51-55.
Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 2010;16:264-275.
Türkiye Endokrinoloji ve Metabolizma (TEMD) Diabetes Mellitus Çalışma ve Eğitim Grubu Raporu. Turk J Endocrinol Metab 2012;16(Suppl 1):150.

APA	İLKOVA H, DAMCI T, Karşıdağ K, ÇÖMLEKÇİ A, ayvaz g (2016). The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. , 88 - 96.
Chicago	İLKOVA Hasan,DAMCI Taner,Karşıdağ Kubilay,ÇÖMLEKÇİ Abdurrahman,ayvaz goksun The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. (2016): 88 - 96.
MLA	İLKOVA Hasan,DAMCI Taner,Karşıdağ Kubilay,ÇÖMLEKÇİ Abdurrahman,ayvaz goksun The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. , 2016, ss.88 - 96.
AMA	İLKOVA H,DAMCI T,Karşıdağ K,ÇÖMLEKÇİ A,ayvaz g The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. . 2016; 88 - 96.
Vancouver	İLKOVA H,DAMCI T,Karşıdağ K,ÇÖMLEKÇİ A,ayvaz g The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. . 2016; 88 - 96.
IEEE	İLKOVA H,DAMCI T,Karşıdağ K,ÇÖMLEKÇİ A,ayvaz g "The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results." , ss.88 - 96, 2016.
ISNAD	İLKOVA, Hasan vd. "The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results". (2016), 88-96.

APA	İLKOVA H, DAMCI T, Karşıdağ K, ÇÖMLEKÇİ A, ayvaz g (2016). The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. Turkish Journal of Endocrinology and Metabolism, 20(3), 88 - 96.
Chicago	İLKOVA Hasan,DAMCI Taner,Karşıdağ Kubilay,ÇÖMLEKÇİ Abdurrahman,ayvaz goksun The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. Turkish Journal of Endocrinology and Metabolism 20, no.3 (2016): 88 - 96.
MLA	İLKOVA Hasan,DAMCI Taner,Karşıdağ Kubilay,ÇÖMLEKÇİ Abdurrahman,ayvaz goksun The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. Turkish Journal of Endocrinology and Metabolism, vol.20, no.3, 2016, ss.88 - 96.
AMA	İLKOVA H,DAMCI T,Karşıdağ K,ÇÖMLEKÇİ A,ayvaz g The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. Turkish Journal of Endocrinology and Metabolism. 2016; 20(3): 88 - 96.
Vancouver	İLKOVA H,DAMCI T,Karşıdağ K,ÇÖMLEKÇİ A,ayvaz g The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results. Turkish Journal of Endocrinology and Metabolism. 2016; 20(3): 88 - 96.
IEEE	İLKOVA H,DAMCI T,Karşıdağ K,ÇÖMLEKÇİ A,ayvaz g "The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results." Turkish Journal of Endocrinology and Metabolism, 20, ss.88 - 96, 2016.
ISNAD	İLKOVA, Hasan vd. "The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results". Turkish Journal of Endocrinology and Metabolism 20/3 (2016), 88-96.